C9 acid

Supramolecules

Namelog KSDpHT(°C)MethodRef
[b-Cyclodextrin](1).[C9 acid] 1.90 0.30 8.2 30.0 capillar zone electrophoresis P. Gareil 1995

Calix[4]arene-based β-cyclodextrin dimer

Supramolecules

Namelog KSDpHT(°C)MethodRef
[Calix[4]arene-based β-cyclodextrin dimer](1).[tetrakis(4-sulfonato)-tetraphenylporphyrin] 5.77 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin dimer](1).[p-Tert-butylbenzyl-functionalized p-pyridylporphyrins] 7.30 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin dimer](2).[p-Tert-butylbenzyl-functionalized p-pyridylporphyrins] 6.60 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin dimer](1).[p-Tert-butylbenzyl-functionalized m-pyridylporphyrins] 6.34 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin dimer](2).[p-Tert-butylbenzyl-functionalized m-pyridylporphyrins] 5.26 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001

Calix[4]arene-based β-cyclodextrin tetramer

Supramolecules

Namelog KSDpHT(°C)MethodRef
[Calix[4]arene-based β-cyclodextrin tetramer](1).[tetrakis(4-sulfonato)-tetraphenylporphyrin] 6.82 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin tetramer](0.5).[tetrakis(4-sulfonato)-tetraphenylporphyrin] 5.91 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin tetramer](1).[p-Tert-butylbenzyl-functionalized p-pyridylporphyrins] 9.70 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin tetramer](2).[p-Tert-butylbenzyl-functionalized p-pyridylporphyrins] 6.70 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin tetramer](1).[iron complex of tetrakis(4-sulfonato)-tetraphenylporphyrin] 6.15 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin tetramer](1).[iron complex of tetrakis(4-sulfonato)-tetraphenylporphyrin] 6.23 7.0 25.0 UV-vis spectroscopy Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin tetramer](0.5).[iron complex of tetrakis(4-sulfonato)-tetraphenylporphyrin] 5.23 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin tetramer](0.5).[iron complex of tetrakis(4-sulfonato)-tetraphenylporphyrin] 5.32 7.0 25.0 UV-vis spectroscopy Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin tetramer](1).[μ-oxo-dimer of the iron complex of tetrakis(4-sulfonato)-tetraphenylporphyrin] 7.18 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin tetramer](1).[μ-oxo-dimer of the iron complex of tetrakis(4-sulfonato)-tetraphenylporphyrin] 7.15 7.0 25.0 UV-vis spectroscopy Jurriaan Huskens 2001
[Calix[4]arene-based β-cyclodextrin tetramer](0.5).[μ-oxo-dimer of the iron complex of tetrakis(4-sulfonato)-tetraphenylporphyrin] 5.62 7.0 25.0 Microcalorimetry Jurriaan Huskens 2001

Carboxymethylated-b-Cyclodextrin (DS ~3.5)

Supramolecules

Namelog KSDpHT(°C)MethodRef
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[metoprolol] 2.56 5.0 HPLC Jong-Seong Kang 2002
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[metoprolol] 2.39 4.0 UV Jong-Seong Kang 2002
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[metoprolol] 2.37 1.28 4.0 CE Jong-Seong Kang 2002
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Noradrenaline] 2.64 NMR Seunho Jung 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 2.98 1.60 3.3 20.0 HPLC-method Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 3.55 2.82 4.4 20.0 HPLC-method Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 3.70 2.98 5.3 20.0 HPLC-method Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 2.96 2.08 6.0 20.0 HPLC-method Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 2.68 1.30 6.5 20.0 HPLC-method Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 2.52 1.43 3.3 20.0 Fluorescence spectroscopy Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 2.62 1.23 4.4 20.0 Fluorescence spectroscopy Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 2.88 1.67 5.3 20.0 Fluorescence spectroscopy Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 3.30 1.46 6.0 20.0 Fluorescence spectroscopy Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 3.31 2.14 6.5 20.0 Fluorescence spectroscopy Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] 2.96 1.76 7.5 20.0 Fluorescence spectroscopy Martin M.F. Choi 2001
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[chlorambucil] 2.86 1.48 7.35 40.0 HPLC-method Thorsteinn Loftsson 1998
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[indomethacin] 1.85 1.00 9.8 40.0 HPLC-method Thorsteinn Loftsson 1998
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[diazepam] 1.00 2.0 30.5 HPLC-method Thorsteinn Loftsson 1998
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–D-PheNH2] 1.66 3.6 20.0 Capillary electrophoresis Gerhard K.E. Scriba 1999
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–D-PheNH2] 1.59 5.25 20.0 Capillary electrophoresis Gerhard K.E. Scriba 1999
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–L-PheNH2] 1.84 3.6 20.0 Capillary electrophoresis Gerhard K.E. Scriba 1999
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–L-PheNH2] 1.43 5.25 20.0 Capillary electrophoresis Gerhard K.E. Scriba 1999
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-D-Asp–D-PheNH2] 1.75 3.6 20.0 Capillary electrophoresis Gerhard K.E. Scriba 1999
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-D-Asp–D-PheNH2] 1.35 5.25 20.0 Capillary electrophoresis Gerhard K.E. Scriba 1999
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[butyric acid] 0.18 -0.10 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[isobutyric acid] 0.49 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[valeric acid] 1.47 0.43 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[isovaleric acid] 1.28 0.23 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[lactic acid] 2.51 1.50 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[succinic acid] 2.43 1.40 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[cadaverine] 1.14 0.04 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[putrescine] 0.94 0.08 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[pyridine ] 0.98 -0.40 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[pyridine ] 1.59 0.56 4.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[3-methyl-pyridine] 1.01 -0.15 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[3-methyl-pyridine] 1.44 0.15 4.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[diphenylamine] 1.92 0.76 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[hydrogen sulfide] 0.22 -0.42 22.0 HS-GCMS Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[methanethiol] -0.46 -1.15 22.0 HS-GCMS Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[dimethyl sulfide] 0.20 -0.82 22.0 HS-GCMS Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[phenyl acetate] 1.82 0.73 8.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[phenyl acetate] 1.39 0.92 4.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[m-cresol] 1.55 0.45 8.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[m-cresol] 0.81 0.38 4.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[phenol ] 1.47 -0.05 8.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[phenol ] 1.36 0.32 4.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[indole] 1.85 0.08 8.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[indole] 1.85 1.25 4.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[skatole] 1.86 0.63 8.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[skatole] 1.94 1.39 4.5 22.0 affinity capillary electrophoresis Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[dodecanol] 1.40 0.48 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[tatradecanol] 1.55 0.40 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[ammonia] 0.36 -0.10 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[methylamine] 0.68 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[L-Ala-L-Phe] 1.98 Capillary electrophoresis Bezhan Chankvetadze 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[D-Ala-D-Phe] 2.02 Capillary electrophoresis Bezhan Chankvetadze 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[L-Phe-L-Phe] 2.14 Capillary electrophoresis Bezhan Chankvetadze 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[D-Phe-D-Phe] 2.19 Capillary electrophoresis Bezhan Chankvetadze 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[ketoconazole] 4.16 2.54 6.0 25.0 UV-vis spectroscopy Joanna Taraszewska 2005
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[ketoconazole] 4.42 3.15 5.0 25.0 UV-vis spectroscopy Joanna Taraszewska 2005
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Safranine T] 2.78 7.2 20.0 Fluorescence spectroscopy Shaomin Shuang 2005
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[doxazosin enantiomer(2)] 2.81 1.74 HPLC Anthony F. Fell 1998
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[dimetindene maleate] 2.08 1.00 3.0 25.0 Capillary electrophoresis Yvette Michotte 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](2).[dimetindene maleate] 2.23 1.00 3.0 25.0 Capillary electrophoresis Yvette Michotte 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[carbinoxamine maleate] 2.26 1.18 3.0 25.0 Capillary electrophoresis Yvette Michotte 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](2).[carbinoxamine maleate] 2.32 1.18 3.0 25.0 Capillary electrophoresis Yvette Michotte 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[homatropine hydrobromide] 1.54 1.28 3.0 25.0 Capillary electrophoresis Yvette Michotte 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](2).[homatropine hydrobromide] 1.68 1.30 3.0 25.0 Capillary electrophoresis Yvette Michotte 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[orciprenaline sulfate] 2.01 1.34 3.0 25.0 Capillary electrophoresis Yvette Michotte 2004
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](2).[orciprenaline sulfate] 2.05 1.32 3.0 25.0 Capillary electrophoresis Yvette Michotte 2004

Cetyltrimethylammonium

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
284.54 0 0 6.17 nt0161 None Not checked

SMILES: CCCCCCCCCCCCCCCC[N+](C)(C)C

Supramolecules

Namelog KSDpHT(°C)MethodRef
[a-Cyclodextrin](1).[Cetyltrimethylammonium] 3.05 25.0 Kenneth A. Connors 1995